Fresenius blood-loss drug gets FDA nod

12/27/2007 | Forbes

The FDA on Thursday approved Frankfurt, Germany-based Fresenius SE's blood-thickening solution Voluven for use in patients who have lost massive amounts of blood. Voluven, which has been found to be as safe as similar solutions, including B. Braun Medical's Hespan, works by increasing the volume of red blood cells and plasma.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA